Arformoterol
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2525 publications
Cost-effectiveness modeling of mortality risk reduction comparing two fixed-dose combination triple therapies in moderate-to-very severe chronic obstructive pulmonary disease.
Journal: Journal of comparative effectiveness research
Published: December 15, 2025
Evaluating the Real-world Effectiveness and Safety of Formoterol Fumarate and Fluticasone Propionate Combination in Asthma: A Prospective, Multicenter Study.
Journal: The Journal of the Association of Physicians of India
Published: November 24, 2025
Improved lung function with beclomethasone/formoterol versus beclomethasone alone in asthma: the FORCE2 study.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: November 13, 2025
Correction to: Real-World Comparative Effectiveness Study in Patients with Asthma Initiating Fluticasone Furoate/Vilanterol or Beclometasone Dipropionate/ Formoterol Fumarate in General Practice in England.
Journal: Advances in therapy
Published: November 01, 2025
IS AS NEEDED THERAPY WITH AN INHALED BUDESONIDE/FORMOTEROL COMBINATION ONLY WHEN SYMPTOMATIC AS AN OPTION IN THE MANAGEMENT OF PATIENTS WITH MILD ASTHMA?
Journal: Arerugi = [Allergy]
Published: October 13, 2025
Budesonide/formoterol for pediatric asthma: bridging the gap between evidence and practice in Maintenance and Reliever Therapy.
Journal: Frontiers in medicine
Published: September 24, 2025
Comments on: "Formoterol, a clinically approved drug, inhibits ferroptosis by suppressing lipid peroxidation and attenuates APAP-induced acute liver injury".
Journal: Chemico-biological interactions
Published: September 17, 2025
Effectiveness and Safety of Glycopyrronium-Formoterol-Budesonide Triple Therapy in Chronic Obstructive Pulmonary Disease (AIR-FORCE): An Open-Label Multi-Centric Phase 4 Study.
Journal: Advances in respiratory medicine
Published: September 16, 2025
Optimizing the Use of Inhaled Corticosteroid/Long-Acting β2-Agonist Combinations in Patients with Moderate-to-Severe Asthma.
Journal: Advances in therapy
Published: September 04, 2025
Real-World Efficacy of Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium on Diaphragmatic Workload Assessed by Ultrasound and Lung Function in Patients with Uncontrolled Asthma.
Journal: Advances in respiratory medicine
Published: August 29, 2025
Stability of formoterol concentration in scalp hair of patients using maintenance formoterol therapy for asthma or COPD (INCTFISH).
Journal: Frontiers in pharmacology
Published: August 27, 2025
TETRIS - Prospective study to observe clinical outcomes of triple therapy in COPD patients: Up to 12 months interim analysis.
Journal: Respiratory medicine
Published: August 19, 2025
Last Updated: 02/24/2026